Located adjacent to the Polar Park baseball stadium in Worcester, the planned Left Field Building is a $16-million symbol of the ambitious plans in the city for the life sciences as a catalyst for its ever-evolving development efforts.
As people around the U.S. turned inward over the last year and a half, consumers appear to have found a respite from the onslaught of technology dependence: reading.
A 24-acre parcel of land at 149 Hayes Memorial Drive on the Marlborough-Northborough border sold to Toronto realty company Oxford Properties Group for $2.1 million, according to the Middlesex South Registry of Deeds.
Hologic, a Marlborough-based medical technology company focused on women’s health, released findings from its first Hologic Global Women’s Health Index, according to a Tuesday press release.
Marlborough medical device manufacturer Boston Scientific Corp. announced Monday a clinical trial for its TheraSphere cancer treatment successfully met both of its primary endpoints.
Akoya Biosciences, a Marlborough bioscience company, has appointed Dr. Myla Lai-Goldman, who has worked extensively in diagnostics and is the chair and co-founder of GeneCentric Therapeutics Inc. of North Carolina, to its board of directors, according to a Wednesday announcement.
Marlborough-based medical device maker Boston Scientific announced on Tuesday it has entered an agreement to acquire California anti-blood clot technology maker Devoro Medical, Inc. of California.
Songs include "Vogue" by Madonna, "Sweet Jane" by The Velvet Underground, "Return of the Mack" by Mark Morrison, "Whatta Man" by Salt-N-Pepa, and "All I Do Is Win" by DJ Khaled.
Marlborough diagnostic company Immunovia, Inc. announced on Monday it has acquired a global license from the South Korean company JW BioScience’s intellectual property portfolio, granting Immunovia global commercial rights for two biomarkers.